Welcome to the UNCOVER Program Website
The UNCOVER Program consists of research studies being conducted to help researchers learn more about an investigational drug being developed for moderate to severe plaque psoriasis. The program will test whether the investigational drug is safe and effective in improving skin condition in individuals with psoriasis.
The studies are being conducted in approximately 20 countries around the world and about 3,750 people with moderate to severe plaque psoriasis will participate.
If you or someone you know suffers from moderate to severe plaque psoriasis, we invite you to learn more about the UNCOVER Program or click here to see if you may qualify to participate.